More details on this developing story will follow.
Definium Therapeutics CEO Robert Barrow sells $721,732 in shares
By Dhallo News · September 5, 2026 at 7:31 AM IST
SOURCE: Investing.com - News
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion
